Sintx Technologies (SINT) AI Stock Analysis

• Market Cap: $7.05M
• Dividend Yield: N/A
• Average Volume (3M): 67.98K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.00
• Revenue Growth: 9.90%
• EPS Growth: 94.56%
• Country: US
• Employees: 20
• Sector: Healthcare
• Sector Strength: 43
• Industry: Medical - Devices
• EPS (TTM): -22.09
• Shares Outstanding: 2,508,706
• 10 Day Avg. Volume: 61,317
• 30 Day Avg. Volume: 67,983
• PEG Ratio: -0.07
• Price to Book (P/B): 0.92
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.02
• Enterprise Value/Market Cap: 0.70
• Enterprise Value/Revenue: 0.42
• Enterprise Value/Gross Profit: 3.58
• Enterprise Value/Ebitda: -0.13
• 1Y Price Target: $30.00
• Price Target Upside: 967.62% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 42 Neutral
• Price Target: ―

Sintx Technologies struggles with financial and operational challenges, evident in its negative profitability and cash flow issues. The technical indicators suggest a bearish sentiment, while its valuation metrics are weak due to ongoing losses. These factors collectively contribute to a low overall stock score.

Positive Factors

Financial Performance

SINTX ended Q4 with $4 million in cash and no debt, and raised approximately $5 million in Q1, suggesting sufficient cash until mid-2026.

Market Potential

The company is aiming for wide commercial opportunities across medical and non-medical industries for silicon nitride, indicating a large market potential.

Share Price Impact

SINT announced a share repurchase plan for up to $500,000, leading to a significant increase in share price.

Negative Factors

Guidance and Forecast

Management again declined to provide forward guidance, which can create uncertainty for investors.

Revenue Growth Uncertainty

There is potential for an extended timeline to grow sales of spinal implants made from silicon nitride.

Revenue Performance

4Q24 revenue was $542K, down 39.9% year-over-year, below the $700K estimate.

Sintx Technologies Business Overview & Revenue Model

Company Description

Sintx Technologies (SINT) is a materials science company specializing in the research, development, and commercialization of advanced ceramics for biomedical and technical applications. The company focuses on creating silicon nitride-based products that are used in various sectors, including medical implants, industrial applications, and defense. Sintx aims to leverage its expertise in ceramics to deliver high-performance solutions that enhance durability and functionality in challenging environments.

How the Company Makes Money

Sintx Technologies generates revenue primarily through the sale of its silicon nitride ceramics products. The company's core revenue streams include the medical sector, where it provides materials for orthopedic and spinal implants, and the industrial sector, where its ceramics are used in wear-resistant and high-temperature applications. Additionally, Sintx pursues collaborative partnerships and licensing agreements with other companies to expand the applications of its technology and increase its market reach. These partnerships often involve joint development projects that can lead to new revenue opportunities. Sintx's focus on innovation and the development of new applications for its materials is a key factor in driving its earnings.

Sintx Technologies Financial Statement Overview

Summary

Sintx Technologies faces significant financial challenges, with ongoing losses and cash flow deficits despite revenue growth. The balance sheet reflects rising leverage and moderate equity levels. While there are positive signs in revenue increase and financing capabilities, substantial operational and profitability hurdles persist.

Income Statement

Sintx Technologies has shown a positive revenue growth trend from $2627k to $2887k in 2024, marking a 9.89% increase year-over-year. However, the company continues to face significant profitability issues with a gross profit margin of 71.94% but a net profit margin of -38.19%, as expenses remain high relative to revenue. The EBIT and EBITDA margins are also negative, indicating ongoing operational challenges.

Balance Sheet

The debt-to-equity ratio has increased to 1.03, suggesting rising leverage, which could pose risks amid persistent losses. The equity ratio stands at 41.36%, showing a moderate reliance on equity financing. Despite net losses, the company's liquidity remains somewhat stable, with cash and short-term investments covering more than half of its liabilities.

Cash Flow

Free cash flow remains negative, though there has been a reduction in the deficit from -$14.6M in 2023 to -$9.3M in 2024. The operating cash flow to net income ratio is negative, reflecting challenges in converting income to cash flow. Despite a positive financing cash flow, the company's ability to generate cash from operations remains a concern.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
2.57M	2.89M	2.63M	601.00K	606.00K	594.00K
	Gross Profit
1.39M	2.08M	1.84M	336.00K	157.00K	119.00K
	EBIT
-13.23M	-14.05M	-13.36M	-11.34M	-10.62M	-9.75M
	EBITDA
-11.53M	-9.61M	-6.60M	-11.06M	-8.63M	-6.53M
	Net Income Common Stockholders
-12.43M	-11.02M	-8.26M	-16.49M	-9.82M	-7.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
6.50M	3.60M	3.34M	6.25M	14.27M	25.35M
	Total Assets
11.45M	9.41M	15.37M	15.77M	21.84M	30.45M
	Total Debt
3.50M	4.03M	4.25M	2.89M	2.40M	2.28M
	Net Debt
-3.00M	427.00K	905.00K	-3.36M	-11.88M	-23.07M
	Total Liabilities
5.36M	5.52M	6.59M	10.07M	4.11M	4.64M
	Stockholders Equity
6.09M	3.89M	8.77M	5.70M	17.73M	25.80M
Cash Flow		Free Cash Flow
-7.79M	-9.33M	-14.64M	-11.67M	-13.87M	-9.47M
	Operating Cash Flow
-7.21M	-8.64M	-14.12M	-10.26M	-10.13M	-9.11M
	Investing Cash Flow
-84.00K	-194.00K	-501.00K	-1.10M	-1.65M	1.75M
	Financing Cash Flow
8.03M	9.09M	11.71M	3.34M	705.00K	30.93M

Sintx Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.81
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SINT, the sentiment is Negative. The current price of 2.81 is below the 20-day moving average (MA) of 2.85, above the 50-day MA of 2.62, and below the 200-day MA of 3.30, indicating a neutral trend. The MACD of 0.15 indicates Negative momentum. The RSI at 50.28 is Neutral, neither overbought nor oversold. The STOCH value of 40.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SINT.

Sintx Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ZBH	70 Outperform	$18.14B	20.32	7.31%	1.03%	3.30%	-2.39%
ATEC	56 Neutral	$1.82B	―	-291.71%	―	25.53%	23.22%
Sector *	53 Neutral	$5.14B	3.06	-43.57%	2.81%	16.81%	-0.12%
OFIX	47 Neutral	$440.00M	―	-27.82%	―	5.85%	-8.92%
SINT	42 Neutral	$7.05M	―	-155.20%	―	9.90%	94.56%

Sintx Technologies Corporate Events

Sintx Technologies Appoints New Chairman of the Board

On March 7, 2025, SINTX Technologies, Inc. appointed Eric K. Olson as the new Chairman of the Board of Directors, succeeding B. Sonny Bal, who remains on the board. This leadership change marks a significant shift in the company’s governance structure, potentially impacting its strategic direction and stakeholder relations.